[Vascular involvements in systemic lupus erythematosus].
It is an established fact that systemic vasculitis can occur during the course of SLE as well as other rheumatic diseases. The principal disorders of SLE are found to be associated with small arteries. However, clinical evidence of arterial disease in SLE patients varies considerably from patient to patient. Clinical manifestations of lupus vasculopathy including vasculitis and microangiopathy were described. Regarding systemic vascular lesions in SLE, the prognosis for the patients with thrombosis and vascular involvement of medium-sized arteries was the most grave. Treatments including steroids, immunosuppressants, plasmapheresis, anticoagulants, etc. are used according to causative factors which result in lupus vasculopathy.
Hashimoto
H
H
Juntendo University, Department of Internal Medicine and Rheumatology.
D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D008180:Lupus Erythematosus, Systemic / Q000150:complications* / Q000503:physiopathology; D008775:Methylprednisolone / Q000008:administration & dosage; D014657:Vasculitis / Q000150:complications* / Q000503:physiopathology / Q000628:therapy
D007166:Immunosuppressive Agents; D008775:Methylprednisolone